RTW Biotech Opportunities Ltd (RTW)
LSE
Closed
Aug 24, 2026
Day's Range
2.5152 wk Range
1.39Overview - RTW - RTW Biotech Opportunities Ltd
Key Statistics
Valuation
Enterprise Value
900.40M
P/E (Trailing)
‪0.04‬
Price / Sales (TTM)
‪24.04‬
Price / Book
‪1.05‬
Profitability
Profit Margin
‪709.18%‬
Operating Margin
‪-43.55%‬
Return on Assets
‪1.42%‬
Return on Equity
‪32.73%‬
Ownership
Shares Outstanding
326.37M
Held by Insiders
‪16.20%‬
Held by Institutions
‪13.74%‬
Price stats
Beta
‪0.77‬
50-Day Avg
‪2.42‬
200-Day Avg
‪2.18‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - RTW - RTW Biotech Opportunities Ltd
Peers - RTW - RTW Biotech Opportunities Ltd
Peer Comparison
Compared with companies in Asset Management listed on LSE.
- RTWLSERTW RetailWinds Inc831.84MMarket Cap+45.74%52-week change0.04P/E (Trailing)‪709.18%‬Profit Margin
- 0NC6LSEInvestor AB ser. B639.65BMarket Cap+27.85%52-week change4.20P/E (Trailing)‪66.89%‬Profit Margin
- ALALWLSEAlliance Witan PLC508.43BMarket Cap+7.45%52-week change19.33P/E (Trailing)—Profit Margin
- ABDNLSEAberdeen Group plc446.93BMarket Cap+18.70%52-week change11.56P/E (Trailing)‪28.06%‬Profit Margin
- 0AAZLSEEQT AB424.93BMarket Cap-2.46%52-week change111.35P/E (Trailing)‪-2.63%‬Profit Margin
- 3INLSE3i Infrastructure plc361.10BMarket Cap+11.24%52-week change12.23P/E (Trailing)‪72.12%‬Profit Margin
- EMGLSEMan Group Plc337.20BMarket Cap+45.46%52-week change14.47P/E (Trailing)‪19.19%‬Profit Margin
Profile Summary - RTW - RTW Biotech Opportunities Ltd
About
RTW Biotech Opportunities Ltd is a Guernsey-domiciled closed-end investment fund specializing in the life sciences sector. It focuses on identifying and investing in transformative assets with high growth potential across biopharmaceuticals and medical technologies, targeting therapies and innovations that address…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
